The Big Short: Why and How It's Happening - Marcia Nusgart, R.Ph. Executive Director Alliance of Wound Care Stakeholders Bethesda, Maryland ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
The Big Short: Why and How It’s Happening Marcia Nusgart, R.Ph. Executive Director Alliance of Wound Care Stakeholders Bethesda, Maryland
The Biggest Change to Health Care Payment Since the Beginning of Medicare- Why? http://www.pgpf.org/analysis/the-medicare-trustees-report-in-charts ($14 BILLION) Medicare Deficit for 2014 2
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) • MACRA was passed in 2015 with bipartisan support to replace the SGR formula. • Legislation passed by Congress that reforms practitioner payment • Without it, Medicare physician payment would have suffered a 25% pay cut • Payment reform targeted advanced practitioners because they determine >80% of spending • With few exceptions, if you see Medicare patients, it affects you 3
Facilitates MIPS and APMs • The long term goal is to get everyone into Alternative Payment Models (APMs) (the final destination) • Accountable Care Organizations • Patient Centered Medical Homes • Bundled Payments • Medicare Shared Savings Program • Initially, most practitioners are subject to the Merit-based Incentive Payment System (MIPS) • When CMS issued the proposed rule on MACRA, the Alliance of Wound Care Stakeholders began preparing its comment letter to CMS. • We asked the simple question, “How do we ensure that wound care patients and practitioners are not overlooked as CMS makes the biggest change to payment in a generation?” • We asked Dr. Sam Nussbaum this question and he said, “CMS pays attention to the conditions that it knows it is spending the most money on. Do you have good data on how much money Medicare is spending on the care of patients with wounds, or indeed what percentage of Medicare beneficiaries have them?” 4
Why Did the Alliance Care about MACRA? ➢ It’s who we are: ▪ We are a non-profit, multidisciplinary “association of clinical associations” and patient organizations ▪ Wound care is multidisciplinary – and so are we. Our members are clinicians of different backgrounds and certifications who TREAT wounds, or are patients with wounds ▪ We come together to have “one voice for wound care” when speaking to regulatory agencies and legislative bodies ➢ Our Mission: ▪ To promote quality care and access to wound care products and services for people with wounds and the clinicians who care for them ▪ Focus on issues of common interest that affect reimbursement and access to care ▪ We work for you through comments submitted on every policy that impacts the coverage of wound care services – currently on OPPS! www.woundcarestakeholders.org ▪ Workplan, Comments, Achievements of the Alliance Monitor policies that impact wound care on our website!
Wound care clinicians treat a symptom of some other specialty’s diagnosis Those other medical specialties often do a very good job of making their voice heard in the halls of Congress!
How much does Medicare spend on chronic wounds? (Even we were surprised by the results.) • Alliance recognized that wound care treatment is Read our MACRA letter! expensive and wanted to inform CMS of this in our 2016 comments on MACRA • Problem: we could not find studies on the true costs of Medicare expenditures on chronic wounds • Most of literature focused on inpatient not outpatient • How could we get the data that was needed? • The Alliance reached out to Joan DaVanzo who has expertise with the Medicare dataset, and to the US Wound Registry, our partner for quality reporting and measure development. • The result was a landmark study, published in Value in Health 2017- “An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds” Samuel R. Nussbaum, MD , Marissa J. Carter, PhD, MA , Caroline E. Fife, MD , Joan DaVanzo, PhD, MSW , Randall Haught , Marcia Nusgart, RPh, Donna Cartwright, MPA • http://www.woundcarestakeholders.org/advocacy/areas-of-focus
Future Trends and Challenges • Aging population creates increasing demand for medical products and services • Cost conscious government and insurance payers- leads to unfavorable payment rates and/or discretionary coverage policies • Need to demonstrate value to patients, payers and the health care system overall • Need to focus on generating new types of data to demonstrate value-- especially in wound care - using real world evidence.
21st Century Cures- we need to find what works • Goal: Bring US Healthcare innovation infrastructure into 21st Century • Advances personalized medicine; emphasizes patient centered outcomes and data • Allows FDA streamline clinical trials, expands trial-design framework, opens door for application of real world evidence (RWE)—pathways for approval of wound products and technologies • Dr. Scott Gottlieb blog- FDA Budget Matters: A Cross- Cutting Data Enterprise for Real World Evidence https://blogs.fda.gov/fdavoice/index.php/tag/real-world- evidence/ How will we take advantage of these changes?
You can also read